icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
ng0Xky7H9yeK4Mk1
Listen
